Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
drugs
2
×
fda
2
×
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
cancer
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
entrectinib
express scripts
foundation medicine
givosiran
indiana blog main
indiana top stories
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
merck
national
national top stories
new england journal of medicine
new york blog main
new york top stories
ntrk
onpattro
patisiran
What
drug
fda
medicine
second
2
×
ago
alnylam
approval
approved
cancer
deeper
dna
fingerprint
genetic
going
indicated
interference
matter
nd
new
nod
oks
pharmaceuticals
quick
rna
rnai
seek
speedy
targets
time
tissues
tumor's
weeks
won’t
world
Language
Current search:
second
×
drugs
×
fda
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
